top of page
Backgrounds.jpg

The voice of Colville and northeastern Washington since 1896

|

September 15, 2026

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Liquidia Corporation - Common Stock (NQ:LQDA)

51.40 +3.53 (+7.37%)
Delayed Quote Updated: 4:00 PM EST, Nov 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Liquidia Corporation - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation Reports Third Quarter 2026 Financial Results
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Report Third Quarter 2026 Financial Results on November 10, 2026
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
LIQUIDIA CORPORATION LQDA INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 57.2% Share Drop
From Kirby McInerney LLP
Via Business Wire
News headline image
Liquidia Announces Global Settlement Resolving All Pending Litigation with United Therapeutics, Ensuring Continued Commercialization of YUTREPIA in PAH
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
LQDA Investors with $100,000 in Losses Have Opportunity to Join Liquidia Corporation Fraud Investigation with SBS Law
From Schall, Brown & Schwartz LLP
Via Business Wire
News headline image
LIQUIDIA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Liquidia Corporation on Behalf of Liquidia Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
LQDA Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Liquidia Corporation (LQDA)
From Levi &amp; Korsinsky, LLP
Via ACCESS Newswire
News headline image
Liquidia Provides Update on Hatch-Waxman Litigation Tied to ‘327 Patent
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation Reports Second Quarter 2026 Financial Results
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation Reports First Quarter 2026 Financial Results
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Participate in Upcoming Investor Conferences
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Participate in Upcoming Investor Conferences
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual Congress
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Host R&D Day in New York City on October 28, 2025
From Liquidia Technologies, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page